Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Laurus Labs Ltd.
NSE: LAURUSLABS
|
BSE: 540222
|
ISIN: INE947Q01028
|
Industry: Pharmaceuticals
|
Expensive Performer
607.3500
4.30
(
0.71
%)
NSE
May 19, 2025
15:31 PM
57.57% Gain from 52W Low
Volume:
2.2M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Laurus Labs Ltd.
30 Apr 2020
607.35
0.71%
Laurus Labs (BUY): Good beat; firm FY21 outlook target raised to Rs 630
Buy:
Laurus Labs Ltd.
by
BOB Capital Markets Ltd.
Target: 630
Target
BOB Capital Markets Ltd.
Laurus Labs reported a strong operational beat of 8%/20%/41% on sales/EBITDA/ PBT in Q4.
Laurus Labs Ltd. has an
average target
of 633.50 from 4 brokers.
More from Laurus Labs Ltd.
Recommended
Market closes lower, Zydus Wellness' Q4 net profit grows 14.4% YoY to Rs 171.9 crore
Trendlyne Marketwatch |
19 May 2025, 03:58PM
IPOs This Week: Belrise Industries, Borana Weaves Plus Two New Issues, and Two Listings Ahead
|
19 May 2025, 02:36PM
Earnings Call Transcript - Q1FY21 for Laurus Labs
|
31 Jul 2020